Corbus Pharma (CRBP) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Form S-3 Corbus Pharmaceuticals
November 10, 2015 5:21 PM ESTTable of Contents
As filed with the Securities and Exchange Commission on November 10, 2015
Registration No. 333-
... More
Form 10-Q Corbus Pharmaceuticals For: Sep 30
November 10, 2015 5:07 PM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC... More
